Related Experiment Video

Updated: Aug 16, 2025

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

38.9K

The Potential Roles of Post-Translational Modifications of PPARγ in Treating Diabetes

Xiaohui Ji1, Wenqian Zhang1, Liqin Yin1

  • 1School of Exercise and Health, Shanghai University of Sport, Shanghai 200433, China.

Biomolecules
|December 23, 2022
PubMed

Insights

Post-translational modifications (PTMs) offer a novel approach to selectively activate peroxisome proliferator-activated receptor γ (PPARγ) for type 2 diabetes mellitus (T2DM) treatment. Understanding these modifications may lead to safer, more effective diabetes medications.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Pharmacology

Background:

  • Type 2 diabetes mellitus (T2DM) is a growing global health challenge, characterized by insulin resistance and deficiency.
  • Peroxisome proliferator-activated receptor γ (PPARγ) is a key regulator of glucose and lipid metabolism and a target for T2DM drugs.
  • Current PPARγ agonists, thiazolidinediones (TZDs), are effective insulin sensitizers but have dose-limiting adverse effects.

Purpose of the Study:

  • To review the role of post-translational modifications (PTMs) in PPARγ function.
  • To explore how PTMs can enable selective PPARγ activation for T2DM treatment.
  • To highlight the potential of PTM-targeted therapies to overcome TZD-related side effects.

Main Methods:

  • Literature review focusing on PTMs of PPARγ.
  • Analysis of PTMs including phosphorylation, acetylation, ubiquitination, SUMOylation, O-GlcNAcylation, and S-nitrosylation.
  • Discussion of the impact of PTMs on PPARγ activity and insulin sensitization.

Main Results:

  • PTMs significantly influence PPARγ activity and its role in glucose and lipid homeostasis.
  • Selective modulation of PPARγ through PTMs presents a strategy to enhance insulin sensitivity.
  • Specific PTMs offer distinct mechanisms for regulating PPARγ, potentially avoiding adverse effects associated with broad activation.

Conclusions:

  • Understanding PPARγ PTMs is crucial for developing novel T2DM therapeutics.
  • Targeting PTMs could lead to safer and more effective insulin-sensitizing drugs.
  • This approach holds promise for a new generation of T2DM treatments with improved safety profiles.
Keywords:
PPARγdiabetespost-translational modificationsthiazolidinediones

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

509
Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies14:56

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies

Published on: May 6, 2022

4.6K

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.7K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.6K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
383
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.8K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.7K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.4K